King, Margaret

Analysis of Developmental Brain Dysfunction in Families

FRAXA Research Foundation 2014 Grants • 2015 Grants • Clinical • Finucane, Brenda • Geisinger Health System • Has Results • King, Margaret September 12, 2015October 10, 2019

FRAXA Research Foundation is proud to make a grant of $90,000 over 2014-2015 to Margaret King, PhD. The goal of this project is to identify new approaches to clinical trial design for Fragile X pharmaceuticals.

Glycogen Synthase Kinase-3 (GSK3), Lithium and Fragile X

FRAXA Research Foundation 2006-2010 Grants • 2011 Grants • 2012 Grants • Has Results • Jope, Richard • King, Margaret • Treatment Targets • University of Miami • Yuskaitis, Christopher September 12, 2013November 14, 2019autism, GSK3, lithium, mGluR5, NIH

With $208,000 in funds from FRAXA Research Foundation, Dr. Richard Jope and his team at the University of Miami tested whether newly developed, highly specific inhibitors of GSK3 can reduce behavioral abnormalities in Fragile X mice.